Note 14 - Segment Information

12 Months Ended

Jun. 30, 2016

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 1

4

.

Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with

GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows:

Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the fiscal years ended June 30, 2016 and 2015 were $7,901 and $8,497, respectively.

Financial information relating to the fiscal years ended

June 30, 2016 and 2015 operations by business segment are as follows:

		Sales, Net			Segment
		U.S.	International		Gross		Capital	Total
		Customers	Customers	Total	Profit (Loss)	Depreciation	Expenditures	Assets
Contract Manufacturing	2016	$ 32,480	$ 7,457	$ 39,937	$ 4,854	$ 244	$ 439	$ 11,853
	2015	26,779	7,478	34,257	3,673	265	421	8,482
Branded Proprietary Products	2016	330	339	669	73	-	-	676
	2015	299	859	1,158	(42)	1	1	1,324
Other Nutraceutical Businesses	2016	1,503	105	1,608	577	2	1	1,556
	2015	1,913	160	2,073	762	2	-	1,817
Total Company	2016	34,313	7,901	42,214	5,504	246	440	14,085
	2015	28,991	8,497	37,488	4,393	268	422	11,623